![Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors](/docs/US/2017-11-07/US09809579B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
-
Application No.: US15381295Application Date: 2016-12-16
-
Publication No.: US09809579B2Publication Date: 2017-11-07
- Inventor: Matthew Dowling , Dilinie Fernando , Kentaro Futatsugi , Kim Huard , Thomas Victor Magee , Brian Raymer , Andre Shavnya , Aaron Smith , Benjamin Thuma , Andy Tsai , Meihua Tu
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Mary J. Hosley
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D403/14 ; C07D403/04 ; C07D401/04 ; A61K31/403
![Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors](/abs-image/US/2017/11/07/US09809579B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Public/Granted literature
- US20170183328A1 SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS Public/Granted day:2017-06-29
Information query
